Pahwa, S., Muresan, P., Sleasman, J., Fenton, T., Moye, J., Deveikis, A., … Pediatric Aids Clinical Trials Study 402 team. (2007). Phase I/II trial of intermittent subcutaneous IL-2 administration in pediatric patients with moderate immune suppression: results of Pediatric AIDS Clinical Trials Study 402. J Allergy Clin Immunol, 119(6), 1538–1541. https://doi.org/10.1016/j.jaci.2006.12.674

Pahwa, Savita, Petronella Muresan, John Sleasman, Terry Fenton, John Moye, Audra Deveikis, Diane Wara, Russ Van Dyke, and Pediatric Aids Clinical Trials Study 402 team. “Phase I/II trial of intermittent subcutaneous IL-2 administration in pediatric patients with moderate immune suppression: results of Pediatric AIDS Clinical Trials Study 402.” J Allergy Clin Immunol 119, no. 6 (June 2007): 1538–41. https://doi.org/10.1016/j.jaci.2006.12.674.

Pahwa S, Muresan P, Sleasman J, Fenton T, Moye J, Deveikis A, et al. Phase I/II trial of intermittent subcutaneous IL-2 administration in pediatric patients with moderate immune suppression: results of Pediatric AIDS Clinical Trials Study 402. J Allergy Clin Immunol. 2007 Jun;119(6):1538–41.

Pahwa, Savita, et al. “Phase I/II trial of intermittent subcutaneous IL-2 administration in pediatric patients with moderate immune suppression: results of Pediatric AIDS Clinical Trials Study 402.” J Allergy Clin Immunol, vol. 119, no. 6, June 2007, pp. 1538–41. Pubmed, doi:10.1016/j.jaci.2006.12.674.

Pahwa S, Muresan P, Sleasman J, Fenton T, Moye J, Deveikis A, Wara D, Van Dyke R, Pediatric Aids Clinical Trials Study 402 team. Phase I/II trial of intermittent subcutaneous IL-2 administration in pediatric patients with moderate immune suppression: results of Pediatric AIDS Clinical Trials Study 402. J Allergy Clin Immunol. 2007 Jun;119(6):1538–1541.